Interleukin-18 and coronary artery lesions in patients with Kawasaki disease

被引:24
作者
Weng, Ken-Pen [1 ,2 ,3 ]
Hsieh, Kai-Sheng [1 ]
Huang, Shih-Hui [4 ]
Ou, Shan-F [5 ]
Lai, Tsung-Jen [6 ]
Tang, Chia-Wan [1 ]
Lin, Chu-Chuan [1 ]
Ho, Tsyr-Yuh [5 ]
Liou, Huei-Han [6 ]
Ger, Luo-Ping [6 ,7 ]
机构
[1] Kaohsiung Vet Gen Hosp, Dept Pediat, Kaohsiung 813, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Dept Pediat, Taipei 112, Taiwan
[3] Shu Zen Coll Med & Management, Kaohsiung, Taiwan
[4] Fooyin Univ, Dept Nursing, Kaohsiung, Taiwan
[5] Zuoying Armed Forces Gen Hosp, Dept Pediat, Kaohsiung, Taiwan
[6] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung 813, Taiwan
[7] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan
关键词
coronary artery lesions; interleukin-18; Kawasaki disease; TUMOR-NECROSIS-FACTOR; GAMMA-GLOBULIN THERAPY; SERUM-LEVELS; INTRAVENOUS IMMUNOGLOBULIN; INTERFERON-GAMMA; PLASMA INTERLEUKIN-18; UNSTABLE ANGINA; ACUTE-PHASE; PREDICTION; ACTIVATION;
D O I
10.1016/j.jcma.2013.04.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Interleukin-18 (IL-18) plays an important role in mediating cytokine cascade leading to coronary artery lesions (CALs) in Kawasaki disease (KM. However, our research suggested that the literature regarding IL-18 and KID is limited. Consequently, this study aimed to evaluate the correlation between IL-18 and CALs in patients with KD. Methods: In this prospective study of 14 children with KD (seven without and seven with CALs in the acute phase), we obtained patient measurements of a series of serum IL-18 levels in the acute, subacute, and convalescent phases. Serum IL-18 levels were measured with a Bio-Plex cytokine assay. Control samples were obtained from 18 febrile children with viral infection. Results: Compared with febrile controls, patients with acute-stage CALs [postintravenous immunoglobulin (post-IVIG) period] had a significantly higher IL-18 level (88.4 +/- 20.7 vs 56.0 +/- 35.0 pg/mL, p = 0.006). However, those without acute-stage CALs (post-WIG period) lacked similarly elevated IL-18 level readings (62.0 +/- 40.6 vs 56.0 +/- 35.0 pg/mL, p = 0.762). The IL-18 level of patients with acute-stage CALs did not decrease significantly until the convalescent phase (97.4 +/- 55.8 vs 38.7 +/- 22.6 pg/mL, p = 0.018), but for those without CALs, it decreased significantly in the subacute phase (60.2 +/- 37.4 vs 23.6 +/- 13.8 pg/mL, p = 0.018). In the subacute stage, there was a significant difference of IL-18 level between patients with and without acute-stage CALs (p = 0.048). Conclusion: Our data show that IL-18 levels were elevated in the acute phase of KD and might be related to the formation of CALs. Copyright (c) 2013 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
引用
收藏
页码:438 / 445
页数:8
相关论文
共 42 条
[1]   Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina [J].
Anguera, I ;
Miranda-Guardiola, F ;
Bosch, X ;
Filella, X ;
Sitges, M ;
Marín, J ;
Betriu, A ;
Sanz, G .
AMERICAN HEART JOURNAL, 2002, 144 (05) :811-817
[2]   Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina [J].
Blankenberg, S ;
Tiret, L ;
Bickel, C ;
Peetz, D ;
Cambien, F ;
Meyer, J ;
Rupprecht, HJ .
CIRCULATION, 2002, 106 (01) :24-30
[3]   High Plasma Interleukin-18 Levels Mark the Acute Phase of Hepatitis C Virus Infection [J].
Chattergoon, Michael A. ;
Levine, Jordana S. ;
Latanich, Rachel ;
Osburn, William O. ;
Thomas, David L. ;
Cox, Andrea L. .
JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (11) :1730-1740
[4]   Interleukin-18 Gene 105A/C Genetic Polymorphism is Associated With the Susceptibility of Kawasaki Disease [J].
Chen, Shih-Yin ;
Wan, Lei ;
Huang, Yu-Chuen ;
Sheu, Jim Jinn-Chyuan ;
Lan, Yu-Ching ;
Lai, Chih-Ho ;
Lin, Cheng-Wen ;
Chang, Jeng Sheng ;
Tsai, Yuhsin ;
Liu, Shih-Ping ;
Lin, Ying-Ju ;
Tsai, Fuu-Jen .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2009, 23 (02) :71-76
[5]   IMMUNE HEMOLYSIS, DISSEMINATED INTRAVASCULAR COAGULATION, AND SERUM SICKNESS AFTER LARGE DOSES OF IMMUNE GLOBULIN GIVEN INTRAVENOUSLY FOR KAWASAKI-DISEASE [J].
COMENZO, RL ;
MALACHOWSKI, ME ;
MEISSNER, HC ;
FULTON, DR ;
BERKMAN, EM .
JOURNAL OF PEDIATRICS, 1992, 120 (06) :926-928
[6]   IL-18:: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family [J].
Dinarello, CA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) :11-24
[7]   Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease [J].
Egami, Kimiyasu ;
Muta, Hiromi ;
Ishii, Masahiro ;
Suda, Kenji ;
Sugahara, Yoko ;
Iemura, Motofumi ;
Matsuishi, Toyojiro .
JOURNAL OF PEDIATRICS, 2006, 149 (02) :237-240
[8]   Prediction of non-responsiveness to intravenous high-dose γ-globulin therapy in patients with Kawasaki disease at onset [J].
Fukunishi, M ;
Kikkawa, M ;
Hamana, K ;
Onodera, T ;
Matsuzaki, K ;
Matsumoto, Y ;
Hara, J .
JOURNAL OF PEDIATRICS, 2000, 137 (02) :172-176
[9]  
FURMANSKI P, 1990, BLOOD, V75, P2328
[10]   PERIPHERAL-BLOOD MONOCYTE MACROPHAGES AND SERUM TUMOR NECROSIS FACTOR IN KAWASAKI DISEASE [J].
FURUKAWA, S ;
MATSUBARA, T ;
JUJOH, K ;
YONE, K ;
SUGAWARA, T ;
SASAI, K ;
KATO, H ;
YABUTA, K .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 48 (02) :247-251